Cortes Lizette M, Mattapallil Mary J, Silver Phyllis B, Donoso Larry A, Liou Gregory I, Zhu Wei, Chan Chi-Chao, Caspi Rachel R
Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.
Invest Ophthalmol Vis Sci. 2008 May;49(5):1946-56. doi: 10.1167/iovs.07-0868.
Interphotoreceptor retinoid binding protein (IRBP) is the major uveitogenic retinal antigen eliciting experimental autoimmune uveoretinitis (EAU) in mice. The most frequently used mouse strains are B10.RIII and C57BL/6, but to date only one uveitogenic epitope for each has been identified. The purpose of this study was to identify and characterize additional uveitogenic epitopes in B10.RIII and C57BL/6 mice and to compare epitope recognition in wild-type versus IRBP-deficient mice on both backgrounds.
Mice were immunized with IRBP. Spleen cells were stimulated in culture with overlapping peptides representing the entire IRBP molecule, and lymphocyte proliferative responses were measured. Peptides determined to be immunodominant were used to immunize mice for EAU. Cytokine profile and proliferation of the CD4 versus CD8 subsets were analyzed for the most pathogenic peptides.
Two new major pathogenic epitopes were identified in WT C57BL/6 mice, residues 461-480 and 651-670. These epitopes induced EAU of severity similar to that induced by the previously known peptide, 1-20. Several other peptides elicited mild disease with lower incidence. Some peptides elicited EAU only in WT recipients of IRBP KO splenocytes. In the B10.RIII strain, two major new uveitogenic peptides were identified, 171-190 and 541-560, and several others elicited moderate disease. Unlike in C57BL/6 mice, adoptive transfer of WT B10.RIII with IRBP KO splenocytes did not reveal additional uveitogenic epitopes. Both CD4 and CD8 lymphocyte subsets proliferated to pathogenic peptides.
Several new pathogenic peptides of IRBP were identified in C57BL/6 and B10.RIII mice. Differences in epitope recognition between WT and IRBP KO mice were observed in C57BL/6 mice, but not in B10.RIII mice, suggesting more extensive culling of the repertoire in C57BL/6 mice by endogenously expressed IRBP.
光感受器间类视黄醇结合蛋白(IRBP)是引发小鼠实验性自身免疫性葡萄膜视网膜炎(EAU)的主要葡萄膜致炎视网膜抗原。最常用的小鼠品系是B10.RIII和C57BL/6,但迄今为止,每种品系仅鉴定出一个葡萄膜致炎表位。本研究的目的是鉴定和表征B10.RIII和C57BL/6小鼠中其他的葡萄膜致炎表位,并比较两种背景下野生型与IRBP缺陷型小鼠的表位识别情况。
用IRBP免疫小鼠。用代表整个IRBP分子的重叠肽在培养中刺激脾细胞,并测量淋巴细胞增殖反应。确定为免疫显性的肽用于免疫小鼠以诱发EAU。分析最具致病性肽的细胞因子谱以及CD4与CD8亚群的增殖情况。
在野生型C57BL/6小鼠中鉴定出两个新的主要致病表位,即第461 - 480位和第651 - 670位氨基酸残基。这些表位诱发的EAU严重程度与先前已知的肽(第1 - 20位氨基酸残基)诱发的相似。其他几种肽诱发的疾病较轻,发病率较低。一些肽仅在接受IRBP基因敲除脾细胞的野生型受体中诱发EAU。在B10.RIII品系中,鉴定出两个主要的新葡萄膜致炎肽,即第171 - 190位和第541 - 560位氨基酸残基,其他几种肽诱发中度疾病。与C57BL/6小鼠不同,将野生型B10.RIII与IRBP基因敲除脾细胞进行过继转移并未发现其他葡萄膜致炎表位。CD4和CD8淋巴细胞亚群均对致病肽发生增殖反应。
在C57BL/6和B10.RIII小鼠中鉴定出了几种新的IRBP致病肽。在C57BL/6小鼠中观察到野生型与IRBP基因敲除小鼠之间在表位识别上存在差异,但在B10.RIII小鼠中未观察到,这表明内源性表达的IRBP对C57BL/6小鼠的库进行了更广泛的筛选。